Literature DB >> 15256537

Genomic organization of mouse orexin receptors: characterization of two novel tissue-specific splice variants.

Jing Chen1, Harpal S Randeva.   

Abstract

In humans and rat, orexins orchestrate divergent actions through their G protein-coupled receptors, orexin-1 (OX1R) and orexin-2 (OX2R). Orexins also play an important physiological role in mouse, but the receptors through which they function are not characterized. To characterize the physiological role(s) of orexins in the mouse, we cloned and characterized the mouse orexin receptor(s), mOX1R and mOX2R, using rapid amplification of cDNA (mouse brain) ends, RT-PCR, and gene structure analysis. The mOX1R cDNA encodes a 416-amino acid (aa) receptor. We have identified two alternative C terminus splice variants of the mOX2R; mOX2 alpha R (443 aa) and mOX2 beta R (460 aa). Binding studies in human embryonic kidney 293 cells transfected with mOX1R, mOX2 alpha R, and the mOX2 beta R revealed specific, saturable sites for both orexin-A and -B. Activation of these receptors by orexins induced inositol triphosphate (IP(3)) turnover. However, human embryonic kidney 293 cells transfected with mOXRs demonstrated no cAMP response to either orexin-A or orexin-B challenge, although forskolin and GTP gamma S revealed a dose-dependent increase in cAMP. Although, orexin-A and -B showed no difference in binding characteristics between the splice variants; interestingly, orexin-B led to an increase in IP(3) production at all concentrations in the mOX2 beta R variant. Orexin-A, however, showed no difference in IP(3) production between the two variants. Additionally, in the mouse, we demonstrate that these splice variants are distributed in a tissue-specific manner, where OX2 alpha R mRNA was undetectable in skeletal muscle and kidney. Moreover, food deprivation led to a greater increase in hypothalamic mOX2 beta R gene expression, compared with both mOX1R and mOX2 alpha R. This potentially implicates a fundamental physiological role for these splice variants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256537     DOI: 10.1210/me.2004-0167

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  8 in total

1.  Orexin/hypocretin receptor signalling: a functional perspective.

Authors:  C S Leonard; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

2.  Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.

Authors:  Xiaoyu Chen; Bo Bai; Yanjun Tian; Hui Du; Jing Chen
Journal:  J Biol Chem       Date:  2014-09-30       Impact factor: 5.157

3.  Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines.

Authors:  J Chen; B Tan; E Karteris; S Zervou; J Digby; E W Hillhouse; M Vatish; H S Randeva
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

4.  Orexin receptors in GtoPdb v.2021.3.

Authors:  Paul Coleman; Luis de Lecea; Anthony Gotter; Jim Hagan; Daniel Hoyer; Thomas Kilduff; Jyrki P Kukkonen; Rod Porter; John Renger; Jerome M Siegel; Gregor Sutcliffe; Neil Upton; Christopher J Winrow
Journal:  IUPHAR BPS Guide Pharm CITE       Date:  2021-09-02

5.  Diurnal inhibition of NMDA-EPSCs at rat hippocampal mossy fibre synapses through orexin-2 receptors.

Authors:  Martina Perin; Fabio Longordo; Christine Massonnet; Egbert Welker; Anita Lüthi
Journal:  J Physiol       Date:  2014-08-01       Impact factor: 5.182

6.  Differential actions of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts: implications for orexinergic signaling in arousal and narcolepsy.

Authors:  Kristi A Kohlmeier; Christopher J Tyler; Mike Kalogiannis; Masaru Ishibashi; Morten P Kristensen; Iryna Gumenchuk; Richard M Chemelli; Yaz Y Kisanuki; Masashi Yanagisawa; Christopher S Leonard
Journal:  Front Neurosci       Date:  2013-12-20       Impact factor: 4.677

7.  Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics.

Authors:  Miles D Thompson; Takeshi Sakurai; Innocenzo Rainero; Mary C Maj; Jyrki P Kukkonen
Journal:  Pharmaceuticals (Basel)       Date:  2017-10-08

8.  Bidirectional and context-dependent changes in theta and gamma oscillatory brain activity in noradrenergic cell-specific Hypocretin/Orexin receptor 1-KO mice.

Authors:  Sha Li; Paul Franken; Anne Vassalli
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.